Abstract
This study examines relationships between patient reported outcomes (PROs) and clinical outcomes in Type 2 diabetes mellitus (T2DM). Patients at the outpatient clinics of a university hospital completed measures of generic health status (SF-12), diabetes-specific quality of life (Audit of Diabetes Dependent Quality of Life – ADDQoL), and depressive symptoms (Center for Epidemiologic Studies Depression – CES-D). Patient reported data were merged with a retrospective collection of clinical and utilization data, including HbA1C, from electronic medical records. A Charlson comorbidity score, diabetes complications score, BMI, and total number of ER and hospital visits were calculated. Usable response rate was 44.3% (n = 385). Patients were dichotomized into glycemic control levels based on the ADA recommended A1C level < 7.0, vs. ≥ 7.0. The ADDQoL, PCS-12, and MCS-12 scores were separately examined as dependent variables using hierarchical regression models, with glycemic control as the primary explanatory variable, and controlling for demographics and clinical variables including comorbidities and complications. Glycemic control was not a significant predictor in any regression model. Obesity was a significant predictor leading to poorer PCS-12 and MCS-12 scores, while depressive symptoms significantly resulted in lower PCS-12, MCS-12 and ADDQoL scores. These and other factors related to self-management behaviors may contribute to a greater understanding of how to intervene with patients with T2DM. The use of such PROs alongside biomedical measures such as A1C is recommended.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- A1C:
-
HbA1C
- ADA:
-
American Diabetes Association
- ADDQoL:
-
Audit of Diabetes Dependent Quality of Life
- ANOVA:
-
Analysis of Variance
- BMI:
-
Body Mass Index
- CES-D:
-
Center for Epidemiologic Studies-Depression
- DCCT:
-
Diabetes Control and Complications Trial
- EMR:
-
Electronic Medical Records
- ER:
-
Emergency Room
- HRQoL:
-
Health-Related Quality of Life
- ICD-9:
-
International Classification of Diseases 9th revision
- MCS-12:
-
Mental Component Summary-12
- PRO:
-
Patient Reported Outcomes
- PCS-12:
-
Physical Component Summary-12
- QoL:
-
Quality of Life
- SF-12:
-
Medical Outcomes Study Short-Form 12
- UKPDS:
-
United Kingdom Prospective Diabetes Study
References
Polonsky WH (2000). Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum 13(1):36
Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG (1997) A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 20:299–305
Rubin RR, Peyrot M (1999) Quality of life and diabetes. Diabetes Metab Res Rev 15:205–218
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986
United Kingdom Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonyl ureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
The Diabetes Control and Complications Trial Research Group (1996) Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 19:195–203
United Kingdom Prospective Diabetes Study Group. (1999) Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 22:1125–1136
Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Schwartz C (1995) Assessment of diabetes- specific distress. Diabetes Care 18:754–60
Van der Does FEE, De Neeling J et al. (1996) Symptoms and well-being in relation to glycemic control in type 2 diabetes. Diabetes Care 19:204–210
Lau C, Qureshi AK, Scott SG (2004) Association between glycaemic control and quality of life in diabetes mellitus. J Postgrad Med 50:189–194
Nerenz DR, Repasky D, Whitehouse FW, Kahkonen DM (1992) Ongoing assessment of health status in patients with diabetes mellitus. Med Care 30(Suppl 5):112–114
Guttmann-Bauman I, Strugger M, Flaherty BP, McEvoy RC (1998) Metabolic control and quality of life assessment in adolescents with IDDM. Diabetes Care 21:915–918
Weinberger M, Kirkman MS, Samsa GP et al. (1994) The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med Care 32:1173–1181
Lloyd A, Sawyer W, Hopkinson P (2001) Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health 4(5):392–400
Bradley C (1996) Measuring quality of life in diabetes. In: Marshall SM, Home PD, Rizza RA (eds), Diabetes Annual 10. Elsevier Science, Amsterdam, pp. 207–227
Bradley C (2001) Importance of differentiating health status tools from quality of life. Lancet 357:7–8
Haffner SM (1998) Epidemiology of type 2 diabetes: Risk factors. Diabetes Care 21(Suppl 3):C3–C6
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999) The disease burden associated with overweight and obesity. JAMA 282:1523–1529
Ford ES, Moriarty DG, Zack MM, Mokdad AH, Chapman DP (2001) Self-reported body mass index and health-related quality of life: Findings from the Behavioral Risk Factor Surveillance System. Obes Res 9:21–31
Hassan MK, Joshi AV, Madhavan SS, Amonkar MM (2003) Obesity and health-related quality of life: a cross-sectional analysis of the US population. Int J Obes Relat Metab Disord 27(10):1227–1232
Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 60(21):3278–3285
De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: A meta-analysis. Psychosom Med 63:619–630
Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults:Is there a link? Diab Care 2000; 23: 1556–1561.
Kaholokula JK, Haynes SN, Grandinetti A, Chang HK (2003) Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes. J Behav Med 26(5):435–458
American Diabetes Association (2005) Standards of medical care in diabetes. Diabetes Care 28(Suppl 1): S4–S36
Buckley A, Goldstein D (1992) Keeping score. Diabetes Educator 19:242–243
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 24(6):1069–1078
Ware JE, Kosinski M, Keller SD (1996) A 12-item Short Form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220–233
Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B. How to score Version 2 of the SF-12 Health Survey (With a Supplement Documenting Version 1). Lilcoln, RI: QualityMetric Incorporated, 2002.
Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R (1999) The development of an individualized Questionnaire measure of perceived impact of diabetes on quality of life: The ADDQoL. Qual Life Res 8:79–91
Bradley C, Speight J (2002) Patient perceptions of diabetes and diabetes therapy: Assessing quality of life. Diabetes Metab Res Rev 18(Suppl 3):S64–S69
Bradley C (2001) Importance of differentiating health status tools from quality of life. Lancet 357:7–8
Garratt AM, Fitzpatrick R, Schmidt L (2002) Patient-assessed health outcome measures for diabetes: A structured review. Diabet Med 19(1):1–11
Wildes KR, Greisinger A, O’Malley KJ. Critical review of quality of life measures for patients with diabetes: Report of the measurement excellence initiative. 2003. Retrieved January 17, 2004, from http://www.measurementexperts. org/criticalReview.htm
Radloff LS (1977) The CES-D scale: A self-report depression scale for research in the general population. Appl Psych Meas 1:385–401
Devins GM, Orme CM, Costello CG et al (1988) Measuring depressive symptoms in illness populations: Psychometric properties of the Centers for Epidemiological Studies Depression (CES-D) scale. Psychol Health 2:139–156
Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ (1977) Assessing depressive symptoms in five psychiatric populations: A validation study. Am J Epidemiol 106(3):203–214
Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L (1997) Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 20(4):562–567
de Sonnaville JJ, Snoek FJ, Colly LP, Deville W, Wijkel D, Heine RJ (1998) Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care 21(6):919–924
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:372–83
D’Hoore W, Bouckaert A, Tilquin C (1996) Practical considerations on the use of the Charlson comorbidity index with administrative databases. J Clin Epidemiol 49(12):1429–1433
Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Lawrence Erlbaum, New Jersey
Centers for Disease Control and Prevention. Body mass index formula for adults. Retrieved January 25, 2005, from http://www.cdc.gov/nccdphp/dnpa/bmi/bmi-adult-formula.htm
Pignone MP, Gaynes BN, Rushton JL et al. (2002) Screening for depression in adults: A summary of the evidence for the U.S. Preventive Services Task Force. Arch Intern Med 136(10):765–776
Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS (2005) Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 161(7):652–660
Tabachnick BG, Fidell LS (1996) Using Multivariate Statistics. Harper Collins, New York
Pedhazur EJ (1997) Multiple Regression in Behavioral Research. Harcourt Brace, Orlando, FL
Sundaram M, Kavookjian J (2005) Quality of life and clinical outcomes in patients with Type 2 diabetes (Abstract). Qual Life Res 14(9):2033
Speight J (2002) Assessing the impact of diabetes screening on quality of life or quality of health? Semantics are important. Diabetes Care 25(10):1983–1984
Woodcock AJ, Julious SA, Kinmoth AL, Campbell MJ (2001) Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual Life Res 10(8):661–670
Jenkinson C. Measuring health and medical outcomes: An overview. In: Measuring Health and Medical Outcomes. UCL Press, London, 1994: 1–6.
Acknowledgements
The authors would like to acknowledge the coordination support provided by the Office of Medical Staff Affairs and the Department of Family Medicine at the West Virginia University Hospitals, in contacting the patients and in obtaining medical history information. We are also grateful to Clare Bradley (Royal Holloway Department of Psychology), and to QualityMetric Inc. for providing us with academic licenses for the use of the ADDQoL and the SF-12, respectively.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s11136-006-9164-2
Rights and permissions
About this article
Cite this article
Sundaram, M., Kavookjian, J., Patrick, J. et al. Quality of life, health status and clinical outcomes in Type 2 diabetes patients. Qual Life Res 16, 165–177 (2007). https://doi.org/10.1007/s11136-006-9105-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-006-9105-0